Lebreton M, Switzer WM, Djoko CF, Gillis A, Jia H, Sturgeon MM, Shankar A, Zheng H, Nkeunen G, Tamoufe U, Nana A, Le Doux-Diffo J, Tafon B, Kiyang J, Schneider BS, Burke DS, Wolfe ND. 2014. A gorilla reservoir for human T-lymphotropic virus type 4. Emerg Microbes Infect 3:e7. http://dx.doi.org/10.1038/emi.2014.7.
Mahieux R, Chappey C, Georges-Courbot MC, Dubreuil G, Mauclere P, Georges A, Gessain A. 1998. Simian T-cell lymphotropic virus type 1 from Mandrillus sphinx as a simian counterpart of human T-cell lymphotropic virus type 1 subtype D. J Virol 72:10316-10322.
Mahieux R, Ibrahim F, Mauclere P, Herve V, Michel P, Tekaia F, Chappey C, Garin B, Van Der Ryst E, Guillemain B, Ledru E, Delaporte E, de The G, Gessain A. 1997. Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies. J Virol 71:1317-1333.
Mahieux R, Pecon-Slattery J, Chen GM, Gessain A. 1998. Evolutionary inferences of novel simian T lymphotropic virus type 1 from wild-caught chacma (Papio ursinus) and olive baboons (Papio anubis). Virology 251: 71-84. http://dx.doi.org/10.1006/viro.1998.9377.
Slattery JP, Franchini G, Gessain A. 1999. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res 9:525-540.
Switzer WM, Qari SH, Wolfe ND, Burke DS, Folks TM, Heneine W. 2006. Ancient origin and molecular features of the novel human Tlymphotropic virus type 3 revealed by complete genome analysis. J Virol 80:7427-7438. http://dx.doi.org/10.1128/JVI.00690-06.
Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, Torimiro JN, Prosser AT, Lebreton M, Mpoudi-Ngole E, Mc-Cutchan FE, Birx DL, Folks TM, Burke DS, Switzer WM. 2005. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci USA 102:7994-7999. http://dx.doi.org/10.1073/pnas.0501734102.
Kazanji M, Mouinga-Ondeme A, Lekana-Douki-Etenna S, Caron M, Makuwa M, Mahieux R, Gessain A. Origin of HTLV-1 in hunters of non-human primates in Central Africa. J Infect Dis, in press.
Locatelli S, Peeters M. 2012. Cross-species transmission of simian retroviruses: how and why they could lead to the emergence of new diseases in the human population. AIDS 26:659-673. http://dx.doi.org/10.1097/QAD.0b013e328350fb68.
Gessain A, Cassar O. 2012. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3:388. http://dx.doi.org/10.3389/fmicb.2012.00388.
Roucoux DF, Murphy EL. 2004. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 6:144-154.
Gessain A, Rua R, Betsem E, Turpin J, Mahieux R. 2013. HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology. Virology 435:187-199. http://dx.doi.org/10.1016/j.virol.2012.09.035.
Mahieux R, Gessain A. 2009. The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol Biol 57:161-166. http://dx.doi.org/10.1016/j.patbio.2008.02.015.
Mahieux R, Gessain A. 2011. HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects. Viruses 3:1074-1090. http://dx.doi.org/10.3390/v3071074.
Busch MP, Switzer WM, Murphy EL, Thomson R, Heneine W. 2000. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results. Transfusion 40:443-449. http://dx.doi.org/10.1046/j.1537-2995.2000.40040443.x.
Duong YT, Jia H, Lust J A, Garcia AD, Tiffany AJ, Heneine W, Switzer WM. 2008. Short communication: absence of evidence of HTLV-3 and HTLV-4 in patients with large granular lymphocyte (LGL) leukemia. AIDS Res Hum Retroviruses 24:1503-1505. http://dx.doi.org/10.1089/aid.2008.0128.
Perzova R, Benz P, Abbott L, Welch C, Thomas A, El Ghoul R, Sanghi S, Nara P, Glaser J, Siegal FP, Dosik H, Poiesz BJ. 2010. Short communication: no evidence of HTLV-3 and HTLV-4 infection in New York State subjects at risk for retroviral infection. AIDS Res Hum Retroviruses 26:1229-1231. http://dx.doi.org/10.1089/aid.2010.0079.
Switzer WM, Salemi M, Qari SH, Jia H, Gray RR, Katzourakis A, Marriott SJ, Pryor KN, Wolfe ND, Burke DS, Folks TM, Heneine W. 2009. Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology 6:9. http://dx.doi.org/10.1186/1742-4690-6-9.
Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R, Gessain A. 2005. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2:30. http://dx.doi.org/10.1186/1742-4690-2-30.
Calattini S, Chevalier SA, Duprez R, Afonso P, Froment A, Gessain A, Mahieux R. 2006. Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein. J Virol 80:9876-9888. http://dx.doi.org/10.1128/JVI.00799-06.
Van Brussel M, Goubau P, Rousseau R, Desmyter J, Vandamme AM. 1997. Complete nucleotide sequence of the new simian T-lymphotropic virus, STLV-PH969 from a Hamadryas baboon, and unusual features of its long terminal repeat. J Virol 71:5464-5472.
Goubau P, Van Brussel M, Vandamme AM, Liu HF, Desmyter J. 1994. A primate T-lymphotropic virus, PTLV-L, different from human Tlymphotropic viruses types I and II, in a wild-caught baboon (Papio hamadryas). Proc Natl Acad Sci USA 91:2848-2852. http://dx.doi.org/10.1073/pnas.91.7.2848.
Meertens L, Mahieux R, Mauclere P, Lewis J, Gessain A. 2002. Complete sequence of a novel highly divergent simian T-cell lymphotropic virus from wild-caught red-capped mangabeys (Cercocebus torquatus) from Cameroon: a new primate T-lymphotropic virus type 3 subtype. J Virol 76:259-268. http://dx.doi.org/10.1128/JVI.76.1.259-268.2002.
Meertens L, Gessain A. 2003. Divergent simian T-cell lymphotropic virus type 3 (STLV-3) in wild-caught Papio hamadryas papio from Senegal: widespread distribution of STLV-3 in Africa. J Virol 77:782-789. http://dx.doi.org/10.1128/JVI.77.1.782-789.2003.
Meertens L, Shanmugam V, Gessain A, Beer BE, Tooze Z, Heneine W, Switzer WM. 2003. A novel, divergent simian T-cell lymphotropic virus type 3 in a wild-caught red-capped mangabey (Cercocebus torquatus torquatus) from Nigeria. J Gen Virol 84:2723-2727. http://dx.doi.org/10.1099/vir.0.19253-0.
Van Dooren S, Shanmugam V, Bhullar V, Parekh B, Vandamme AM, Heneine W, Switzer WM. 2004. Identification in gelada baboons (Theropithecus gelada) of a distinct simian T-cell lymphotropic virus type 3 with a broad range of Western blot reactivity. J Gen Virol 85:507-519. http://dx.doi.org/10.1099/vir.0.19630-0.
Courgnaud V, Van Dooren S, Liegeois F, Pourrut X, Abela B, Loul S, Mpoudi-Ngole E, Vandamme A, Delaporte E, Peeters M. 2004. Simian T-cell leukemia virus (STLV) infection in wild primate populations in Cameroon: evidence for dual STLV type 1 and type 3 infection in agile mangabeys (Cercocebus agilis). J Virol 78:4700-4709. http://dx.doi.org/10.1128/JVI.78.9.4700-4709.2004.
Liegeois F, Boue V, Mouacha F, Butel C, Ondo BM, Pourrut X, Leroy E, Peeters M, Rouet F. 2012. New STLV-3 strains and a divergent SIVmus strain identified in non-human primate bushmeat in Gabon. Retrovirology 9:28. http://dx.doi.org/10.1186/1742-4690-9-28.
Ahuka-Mundeke S, Mbala-Kingebeni P, Liegeois F, Ayouba A, Lunguya-Metila O, Demba D, Bilulu G, Mbenzo-Abokome V, Inogwabini BI, Muyembe-Tamfum JJ, Delaporte E, Peeters M. 2012. Identification and molecular characterization of new simian T cell lymphotropic viruses in nonhuman primates bushmeat from the Democratic Republic of Congo. AIDS Res Hum Retroviruses 28:628-635. http://dx.doi.org/10.1089/aid.2011.0211.
Calattini S, Betsem E, Bassot S, Chevalier SA, Tortevoye P, Njouom R, Mahieux R, Froment A, Gessain A. 2011. Multiple retroviral infection by HTLV type 1, 2, 3 and simian foamy virus in a family of Pygmies from Cameroon. Virology 410:48-55. http://dx.doi.org/10.1016/j.virol.2010.10.025.
Zheng H, Wolfe ND, Sintasath DM, Tamoufe U, Lebreton M, Djoko CF, Le Doux Diffo J, Pike BL, Heneine W, Switzer WM. 2010. Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon. Virology 401:137-145. http://dx.doi.org/10.1016/j.virol.2010.03.010.
Sintasath DM, Wolfe ND, Lebreton M, Jia H, Garcia AD, Le Doux-Diffo J, Tamoufe U, Carr JK, Folks TM, Mpoudi-Ngole E, Burke DS, Heneine W, Switzer WM. 2009. Simian T-lymphotropic virus diversity among nonhuman primates, Cameroon. Emerg Infect Dis 15:175-184. http://dx.doi.org/10.3201/eid1502.080584.
Calattini S, Betsem E, Bassot S, Chevalier SA, Mahieux R, Froment A, Gessain A. 2009. New strain of human T lymphotropic virus (HTLV) type 3 in a Pygmy from Cameroon with peculiar HTLV serologic results. J Infect Dis 199:561-564. http://dx.doi.org/10.1086/596206.
Liegeois F, Lafay B, Switzer WM, Locatelli S, Mpoudi-Ngole E, Loul S, Heneine W, Delaporte E, Peeters M. 2008. Identification and molecular characterization of new STLV-1 and STLV-3 strains in wild-caught nonhuman primates in Cameroon. Virology 371:405-417. http://dx.doi.org/10.1016/j.virol.2007.09.037.
Takemura T, Yamashita M, Shimada MK, Ohkura S, Shotake T, Ikeda M, Miura T, Hayami M. 2002. High prevalence of simian Tlymphotropic virus type L in wild Ethiopian baboons. J Virol 76:1642-1648. http://dx.doi.org/10.1128/JVI.76.4.1642-1648.2002.
Van Dooren S, Salemi M, Pourrut X, Peeters M, Delaporte E, Van Ranst M, Vandamme AM. 2001. Evidence for a second simian T-cell lymphotropic virus type 3 in Cercopithecus nictitans from Cameroon. J Virol 75: 11939-11941. http://dx.doi.org/10.1128/JVI.75.23.11939-11941.2001.
Matsuoka M, Yasunaga J. 2013. Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor. Curr Opin Virol 3:684-691. http://dx.doi.org/10.1016/j.coviro.2013.08.010.
Chevalier SA, Meertens L, Pise-Masison C, Calattini S, Park H, Alhaj AA, Zhou M, Gessain A, Kashanchi F, Brady JN, Mahieux R. 2006. The Tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2Tax. Oncogene 25:4470-4482. http://dx.doi.org/10.1038/sj.onc.1209472.
Chevalier SA, Durand S, Dasgupta A, Radonovich M, Cimarelli A, Brady JN, Mahieux R, Pise-Masison CA. 2012. The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties. PLoS One 7:e41003. http://dx.doi.org/10.1371/journal.pone.0041003.
Larocque E, Halin M, Landry S, Marriott SJ, Switzer WM, Barbeau B. 2011. Human T-cell lymphotropic virus type 3 (HTLV-3)-and HTLV-4-derived antisense transcripts encode proteins with similar Taxinhibiting functions but distinct subcellular localization. J Virol 85: 12673-12685. http://dx.doi.org/10.1128/JVI.05296-11.
Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM. 2002. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 76:12813-12822. http://dx.doi.org/10.1128/JVI.76.24.12813-12822.2002.
Halin M, Douceron E, Clerc I, Journo C, Ko NL, Landry S, Murphy EL, Gessain A, Lemasson I, Mesnard JM, Barbeau B, Mahieux R. 2009. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood 114:2427-2438. http://dx.doi.org/10.1182/blood-2008-09-179879.
Journo C, Douceron E, Mahieux R. 2009. HTLV gene regulation: because size matters, transcription is not enough. Future Microbiol 4:425-440. http://dx.doi.org/10.2217/fmb.09.13.
Edwards D, Fenizia C, Gold H, de Castro-Amarante MF, Buchmann C, Pise-Masison CA, Franchini G. 2011. Orf-I and Orf-II-encoded proteins in HTLV-1 infection and persistence. Viruses 3:861-885. http://dx.doi.org/10.3390/v3060861.
Anupam R, Doueiri R, Green PL. 2013. The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle. Front Microbiol 4:275. http://dx.doi.org/10.3389/fmicb.2013.00275.
Bai XT, Baydoun HH, Nicot C. 2010. HTLV-I p30: a versatile protein modulating virus replication and pathogenesis. Mol Aspects Med 31: 344-349. http://dx.doi.org/10.1016/j.mam.2010.05.004.
Younis I, Boris-Lawrie K, Green PL. 2006. Human T-cell leukemia virus open reading frame II encodes a posttranscriptional repressor that is recruited at the level of transcription. J Virol 80:181-191. http://dx.doi.org/10.1128/JVI.80.1.181-191.2006.
Younis I, Khair L, Dundr M, Lairmore MD, Franchini G, Green PL. 2004. Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol 78:11077-11083. http://dx.doi.org/10.1128/JVI.78.20.11077-11083.2004.
Ghorbel S, Sinha-Datta U, Dundr M, Brown M, Franchini G, Nicot C. 2006. Human T-cell leukemia virus type I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit. J Biol Chem 281:37150-37158. http://dx.doi.org/10.1074/jbc.M603981200.
Zhang W, Nisbet JW, Bartoe JT, Ding W, Lairmore MD. 2000. Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters. J Virol 74: 11270-11277. http://dx.doi.org/10.1128/JVI.74.23.11270-11277.2000.
Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G. 2004. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med 10:197-201. http://dx.doi.org/10.1038/nm984.
Sinha-Datta U, Datta A, Ghorbel S, Dodon MD, Nicot C. 2007. Human T-cell lymphotrophic virus type I rex and p30 interactions govern the switch between virus latency and replication. J Biol Chem 282: 14608-14615. http://dx.doi.org/10.1074/jbc.M611219200.
Datta A, Sinha-Datta U, Dhillon NK, Buch S, Nicot C. 2006. The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro-and anti-inflammatory cytokines from human macrophages. J Biol Chem 281:23414-23424. http://dx.doi.org/10.1074/jbc.M600684200.
Silic-Benussi M, Biasiotto R, Andresen V, Franchini G, D'Agostino DM, Ciminale V. 2010. HTLV-1 p13, a small protein with a busy agenda. Mol Aspects Med 31:350-358. http://dx.doi.org/10.1016/j.mam.2010.03.001.
Andresen V, Pise-Masison CA, Sinha-Datta U, Bellon M, Valeri V, Washington Parks R, Cecchinato V, Fukumoto R, Nicot C, Franchini G. 2011. Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles. Blood 118:1549-1559. http://dx.doi.org/10.1182/blood-2010-06-293340.
Silic-Benussi M, Cavallari I, Zorzan T, Rossi E, Hiraragi H, Rosato A, Horie K, Saggioro D, Lairmore MD, Willems L, Chieco-Bianchi L, D'Agostino DM, Ciminale V. 2004. Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc Natl Acad Sci USA 101:6629-6634. http://dx.doi.org/10.1073/pnas.0305502101.
Silic-Benussi M, Marin O, Biasiotto R, D'Agostino DM, Ciminale V. 2010. Effects of human T-cell leukemia virus type 1 (HTLV-1) p13 on mitochondrial K+ permeability: a new member of the viroporin family? FEBS Lett 584:2070-2075. http://dx.doi.org/10.1016/j.febslet.2010.02.030.
Albrecht B, Collins ND, Burniston MT, Nisbet JW, Ratner L, Green PL, Lairmore MD. 2000. Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes. J Virol 74:9828-9835. http://dx.doi.org/10.1128/JVI.74.21.9828-9835.2000.
Ding W, Albrecht B, Luo R, Zhang W, Stanley JR, Newbound GC, Lairmore MD. 2001. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J Virol 75:7672-7682. http://dx.doi.org/10.1128/JVI.75.16.7672-7682.2001.
Nicot C, Mulloy JC, Ferrari MG, Johnson JM, Fu K, Fukumoto R, Trovato R, Fullen J, Leonard WJ, Franchini G. 2001. HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood 98:823-829. http://dx.doi.org/10.1182/blood.V98.3.823.
Ding W, Albrecht B, Kelley RE, Muthusamy N, Kim SJ, Altschuld RA, Lairmore MD. 2002. Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J Virol 76:10374-10382. http://dx.doi.org/10.1128/JVI.76.20.10374-10382.2002.
Ding W, Kim SJ, Nair AM, Michael B, Boris-Lawrie K, Tripp A, Feuer G, Lairmore MD. 2003. Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation. J Virol 77: 11027-11039. http://dx.doi.org/10.1128/JVI.77.20.11027-11039.2003.
Fukumoto R, Andresen V, Bialuk I, Cecchinato V, Walser JC, Valeri VW, Nauroth JM, Gessain A, Nicot C, Franchini G. 2009. In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. Blood 113:3726-3734. http://dx.doi.org/10.1182/blood-2008-04-146928.
Van Prooyen N, Andresen V, Gold H, Bialuk I, Pise-Masison C, Franchini G. 2010. Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins. Mol Aspects Med 31:333-343. http://dx.doi.org/10.1016/j.mam.2010.07.001.
Van Prooyen N, Gold H, Andresen V, Schwartz O, Jones K, Ruscetti F, Lockett S, Gudla P, Venzon D, Franchini G. 2010. Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission. Proc Natl Acad Sci USA 107:20738-20743. http://dx.doi.org/10.1073/pnas.1009635107.
Chevalier SA, Walic M, Calattini S, Mallet A, Prevost MC, Gessain A, Mahieux R. 2007. Construction and characterization of a full-length infectious simian T-cell lymphotropic virus type 3 molecular clone. J Virol 81:6276-6285. http://dx.doi.org/10.1128/JVI.02538-06.
Artimo P, Jonnalagedda M, Arnold K, Baratin D, Csardi G, de Castro E, Duvaud S, Flegel V, Fortier A, Gasteiger E, Grosdidier A, Hernandez C, Ioannidis V, Kuznetsov D, Liechti R, Moretti S, Mostaguir K, Redaschi N, Rossier G, Xenarios I, Stockinger H. 2012. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res 40:W597-W603. http://dx.doi.org/10.1093/nar/gks400.
Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98 NT. Nucleic Acids Symp Ser 41:95-98.
Fukumoto R, Dundr M, Nicot C, Adams A, Valeri VW, Samelson LE, Franchini G. 2007. Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1. J Virol 81: 9088-9099. http://dx.doi.org/10.1128/JVI.02703-06.
Kress E, Baydoun HH, Bex F, Gazzolo L, Duc Dodon M. 2005. Critical role of hnRNP A1 in HTLV-1 replication in human transformed T lymphocytes. Retrovirology 2:8. http://dx.doi.org/10.1186/1742-4690-2-8.
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676-682. http://dx.doi.org/10.1038/nmeth.2019.
Bolte S, Cordelieres FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213-232. http://dx.doi.org/10.1111/j.1365-2818.2006.01706.x.
Berger G, Turpin J, Cordeil S, Tartour K, Nguyen XN, Mahieux R, Cimarelli A. 2012. Functional analysis of the relationship between Vpx and the restriction factor SAMHD1. J Biol Chem 287:41210-41217. http://dx.doi.org/10.1074/jbc.M112.403816.
Chevalier SA, Turpin J, Cachat A, Afonso PV, Gessain A, Brady JN, Pise-Masison CA, Mahieux R. 2014. Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission. PLoS Pathog 10:e1003917. http://dx.doi.org/10.1371/journal.ppat.1003917.
Larocque E, Andre-Arpin C, Borowiak M, Lemay G, Switzer WM, Duc Dodon M, Mesnard JM, Barbeau B. 2014. Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif. J Virol 88:8956-8970. http://dx.doi.org/10.1128/JVI.01094-14.
Higuchi M, Tsubata C, Kondo R, Yoshida S, Takahashi M, Oie M, Tanaka Y, Mahieux R, Matsuoka M, Fujii M. 2007. Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line. J Virol 81:11900-11907. http://dx.doi.org/10.1128/JVI.00532-07.
Boxus M, Twizere JC, Legros S, Kettmann R, Willems L. 2012. Interaction of HTLV-1 Tax with minichromosome maintenance proteins accelerates the replication timing program. Blood 119:151-160. http://dx.doi.org/10.1182/blood-2011-05-356790.
Van Brussel M, Goubau P, Rousseau R, Desmyter J, Vandamme AM. 1996. The genomic structure of a new simian T-lymphotropic virus, STLV-PH969, differs from that of human T-lymphotropic virus types I and II. J Gen Virol 77(Part 2):347-358.
Cavallari I, Rende F, Bender C, Romanelli MG, D'Agostino DM, Ciminale V. 2013. Fine tuning of the temporal expression of HTLV-1 and HTLV-2. Front Microbiol 4:235. http://dx.doi.org/10.3389/fmicb.2013.00235.
Cavallari I, Rende F, Ciminale V. 2014. Quantitative analysis of human T-lymphotropic virus type 1 (HTLV-1) gene expression using nucleocytoplasmic fractionation and splice junction-specific real-time RT-PCR (qRT-PCR). Methods Mol Biol 1087:325-337. http://dx.doi.org/10.1007/978-1-62703-670-2_26.
Li M, Green PL. 2007. Detection and quantitation of HTLV-1 and HTLV-2mRNAspecies by real-time RT-PCR. J Virol Methods 142:159-168. http://dx.doi.org/10.1016/j.jviromet.2007.01.023.
Ciminale V, Pavlakis GN, Derse D, Cunningham CP, Felber BK. 1992. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J Virol 66:1737-1745.
Rende F, Cavallari I, Corradin A, Silic-Benussi M, Toulza F, Toffolo GM, Tanaka Y, Jacobson S, Taylor GP, D'Agostino DM, Bangham CR, Ciminale V. 2011. Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. Blood 117: 4855-4859. http://dx.doi.org/10.1182/blood-2010-11-316463.
Bender C, Rende F, Cotena A, Righi P, Ronzi P, Cavallari I, Casoli C, Ciminale V, Bertazzoni U. 2012. Temporal regulation of HTLV-2 expression in infected cell lines and patients: evidence for distinct expression kinetics with nuclear accumulation of APH-2 mRNA. Retrovirology 9:74. http://dx.doi.org/10.1186/1742-4690-9-74.
Alexandersen S, Carpenter S, Christensen J, Storgaard T, Viuff B, Wannemuehler Y, Belousov J, Roth JA. 1993. Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol 67:39-52.
Nosaka T, Siomi H, Adachi Y, Ishibashi M, Kubota S, Maki M, Hatanaka M. 1989. Nucleolar targeting signal of human T-cell leukemia virus type I rex-encoded protein is essential for cytoplasmic accumulation of unspliced viral mRNA. Proc Natl Acad Sci USA 86:9798-9802. http://dx.doi.org/10.1073/pnas.86.24.9798.
Siomi H, Shida H, Nam SH, Nosaka T, Maki M, Hatanaka M. 1988. Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell 55:197-209. http://dx.doi.org/10.1016/0092-8674(88)90043-8.
Ciminale V, D'Agostino DM, Zotti L, Franchini G, Felber BK, Chieco-Bianchi L. 1995. Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology 209:445-456. http://dx.doi.org/10.1006/viro.1995.1277.
Bartoe JT, Albrecht B, Collins ND, Robek MD, Ratner L, Green PL, Lairmore MD. 2000. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.J Virol 74:1094-1100. http://dx.doi.org/10.1128/JVI.74.3.1094-1100.2000.
Silverman LR, Phipps AJ, Montgomery A, Ratner L, Lairmore MD. 2004. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol 78:3837-3845. http://dx.doi.org/10.1128/JVI.78.8.3837-3845.2004.
Bai XT, Nicot C. 2012. Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis. Front Microbiol 3:400. http://dx.doi.org/10.3389/fmicb.2012.00400.
Berneman ZN, Gartenhaus RB, Reitz MS, Jr, Blattner WA, Manns A, Hanchard B, Ikehara O, Gallo RC, Klotman ME. 1992. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc Natl Acad Sci USA 89:3005-3009. http://dx.doi.org/10.1073/pnas.89.7.3005.
Koralnik IJ, Gessain A, Klotman ME, Lo Monico A, Berneman ZN, Franchini G. 1992. Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc Natl Acad Sci USA 89:8813-8817.
Pique C, Ureta-Vidal A, Gessain A, Chancerel B, Gout O, Tamouza R, Agis F, Dokhelar MC. 2000. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J Exp Med 191:567-572. http://dx.doi.org/10.1084/jem.191.3.567.
Iniguez AM, Gastaldello R, Gallego S, Otsuki K, Vicente AC. 2006. HTLV-1 p12I protein sequences from South America: truncated proteins and common genetic signatures. AIDS Res Hum Retroviruses 22: 466-469. http://dx.doi.org/10.1089/aid.2006.22.466.
Kim SJ, Ding W, Albrecht B, Green PL, Lairmore MD. 2003. A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation. J Biol Chem 278:15550-15557. http://dx.doi.org/10.1074/jbc.M210210200.
Saksena NK, Srinivasan A, Ge YC, Xiang SH, Azad A, Bolton W, Herve V, Reddy S, Diop O, Miranda-Saksena M, Rawlinson WD, Vandamme AM, Barre-Sinoussi F. 1997. Simian T cell leukemia virus type I from naturally infected feral monkeys from Central and West Africa encodes a 91-amino acid p12 (ORF-I) protein as opposed to a 99-amino acid protein encoded by HTLV type I from humans. AIDS Res Hum Retroviruses 13: 425-432. http://dx.doi.org/10.1089/aid.1997.13.425.
Dube S, Love JL, Dube DK, Leon-Ponte M, de Perez GE, Baroja ML, Bianco N, Poiesz BJ. 1999. The complete genomic sequence of an HTLV-II isolate from a Guahibo Indian from Venezuela. Virology 253: 181-192. http://dx.doi.org/10.1006/viro.1998.9515.
Van Brussel M, Salemi M, Liu HF, Gabriels J, Goubau P, Desmyter J, Vandamme AM. 1998. The simian T-lymphotropic virus STLV-PP1664 from Pan paniscus is distinctly related to HTLV-2 but differs in genomic organization. Virology 243:366-379. http://dx.doi.org/10.1006/viro.1998.9075.
Pavesi A, Magiorkinis G, Karlin DG. 2013. Viral proteins originated de novo by overprinting can be identified by codon usage: application to the "gene nursery" of deltaretroviruses. PLoS Comput Biol 9:e1003162. http://dx.doi.org/10.1371/journal.pcbi.1003162.
Johnson JM, Nicot C, Fullen J, Ciminale V, Casareto L, Mulloy JC, Jacobson S, Franchini G. 2001. Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein. J Virol 75: 6086-6094. http://dx.doi.org/10.1128/JVI.75.13.6086-6094.2001.
Sintasath DM, Wolfe ND, Zheng HQ, LeBreton M, Peeters M, Tamoufe U, Djoko CF, Diffo JL, Mpoudi-Ngole E, Heneine W, Switzer WM. 2009. Genetic characterization of the complete genome of a highly divergent simian T-lymphotropic virus (STLV) type 3 from a wild Cercopithecus mona monkey. Retrovirology 6:97. http://dx.doi.org/10.1186/1742-4690-6-97.
